featured
Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients With Muscle-Invasive Bladder Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Journal of Urology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer
J Urol 2022 Jan 01;207(1)70-76, D D'Andrea, PC Black, H Zargar, CP Dinney, F Soria, MS Cookson, JS Montgomery, W Kassouf, MA Dall'Era, SS Sridhar, JS McGrath, JL Wright, AC Thorpe, JM Holzbeierlein, DM Carrión, E Di Trapani, TJ Bivalacqua, S North, DA Barocas, Y Lotan, P Grivas, AJ Stephenson, BW van Rhijn, S Daneshmand, PE Spiess, SF ShariatFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.